Julie Zhen Qin Wu

Array ( [id] => 6576656 [patent_doc_number] => 20100047241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'FUNCTIONAL HEAVY CHAIN ANTIBODIES, FRAGMENTS THEREOF, LIBRARY THEREOF AND METHODS OF PRODUCTION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/498835 [patent_app_country] => US [patent_app_date] => 2009-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21489 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047241.pdf [firstpage_image] =>[orig_patent_app_number] => 12498835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062159 [patent_doc_number] => 20110200594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'FUNCTIONALIZED POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/000499 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8248 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200594.pdf [firstpage_image] =>[orig_patent_app_number] => 13000499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9523589 [patent_doc_number] => 08747848 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Immunoglobulins with reduced aggregation' [patent_app_type] => utility [patent_app_number] => 13/000351 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28480 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13000351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601405 [patent_doc_number] => 20100322936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'LM-1 ANTIBODIES, FUNCTIONAL FRAGMENTS, LM-1 TARGET ANTIGEN, AND METHODS FOR MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 12/484476 [patent_app_country] => US [patent_app_date] => 2009-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 53959 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322936.pdf [firstpage_image] =>[orig_patent_app_number] => 12484476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095252 [patent_doc_number] => 20110002903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'IMMUNOGENIC CONTROL OF TUMOURS AND TUMOUR CELLS' [patent_app_type] => utility [patent_app_number] => 12/735740 [patent_app_country] => US [patent_app_date] => 2009-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13149 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002903.pdf [firstpage_image] =>[orig_patent_app_number] => 12735740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465065 [patent_doc_number] => 20120270233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'ASSOCIATION OF BIOMARKERS WITH PATIENT OUTCOME' [patent_app_type] => utility [patent_app_number] => 12/866836 [patent_app_country] => US [patent_app_date] => 2009-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 11154 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12866836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6608290 [patent_doc_number] => 20100323381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'CLASSIFYING AMYLOIDOSIS' [patent_app_type] => utility [patent_app_number] => 12/866709 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11615 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323381.pdf [firstpage_image] =>[orig_patent_app_number] => 12866709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343501 [patent_doc_number] => 20100330093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH ANTIBODIES AGAINST CYTOTOXIC T LYMPHOCYTE-ASSOCIATED ANTIGEN 4 (CTLA4)' [patent_app_type] => utility [patent_app_number] => 12/747817 [patent_app_country] => US [patent_app_date] => 2008-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2785 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330093.pdf [firstpage_image] =>[orig_patent_app_number] => 12747817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142143 [patent_doc_number] => 20110129459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'ANTI-NR10 ANTIBODY AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/745781 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 37953 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129459.pdf [firstpage_image] =>[orig_patent_app_number] => 12745781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9761717 [patent_doc_number] => 08846036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Antibodies that bind to mammalian NGAL and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/329357 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 29 [patent_no_of_words] => 35420 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12329357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5277969 [patent_doc_number] => 20090130101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'ANTI-CANCER THERAPY WITH AN EXTRACT OF SCUTELLARIA BARBATA' [patent_app_type] => utility [patent_app_number] => 12/274251 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24698 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130101.pdf [firstpage_image] =>[orig_patent_app_number] => 12274251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6416665 [patent_doc_number] => 20100306867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'TRANSGENIC ANIMALS PRODUCING MONOVALENT HUMAN ANTIBODIES AND ANTIBODIES OBTAINABLE FROM THESE ANIMALS' [patent_app_type] => utility [patent_app_number] => 12/602419 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 32679 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20100306867.pdf [firstpage_image] =>[orig_patent_app_number] => 12602419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410123 [patent_doc_number] => 20090124022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'ANTIBODIES THAT BIND TO MAMMALIAN NGAL AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/104413 [patent_app_country] => US [patent_app_date] => 2008-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 34073 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124022.pdf [firstpage_image] =>[orig_patent_app_number] => 12104413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4681776 [patent_doc_number] => 20080248002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'ANTI-ANGIOGENIC CELLULAR AGENT FOR CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 12/058524 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11059 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248002.pdf [firstpage_image] =>[orig_patent_app_number] => 12058524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807462 [patent_doc_number] => 20080171040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'ANTIBODY-DRUG CONJUGATES AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/052938 [patent_app_country] => US [patent_app_date] => 2008-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 40713 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171040.pdf [firstpage_image] =>[orig_patent_app_number] => 12052938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10850528 [patent_doc_number] => 08877206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-04 [patent_title] => 'Stimulation of an immune response by cationic lipids' [patent_app_type] => utility [patent_app_number] => 12/049957 [patent_app_country] => US [patent_app_date] => 2008-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 44 [patent_no_of_words] => 23978 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12049957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6436338 [patent_doc_number] => 20100143912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'SPECIFIC N-TERMINAL LABELING OF PEPTIDES AND PROTEINS IN COMPLEX MIXTURES' [patent_app_type] => utility [patent_app_number] => 12/524557 [patent_app_country] => US [patent_app_date] => 2008-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15979 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143912.pdf [firstpage_image] =>[orig_patent_app_number] => 12524557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954511 [patent_doc_number] => 20080187535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'VACCINE' [patent_app_type] => utility [patent_app_number] => 12/013011 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12333 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187535.pdf [firstpage_image] =>[orig_patent_app_number] => 12013011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9139807 [patent_doc_number] => 08580263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/515522 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 27606 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12515522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663605 [patent_doc_number] => 20080254512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Hybrid immunoglobulins with moving parts' [patent_app_type] => utility [patent_app_number] => 11/982085 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 90 [patent_no_of_words] => 65288 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254512.pdf [firstpage_image] =>[orig_patent_app_number] => 11982085 [rel_patent_id] =>[rel_patent_doc_number] =>)